Evidence map›Paper›PMID 19684627›Full record

ArticleBone marrow transplantation2010

Successful SCT for Nijmegen breakage syndrome.

M H Albert, A R Gennery, J Greil, C M Cale, K Kalwak, I Kondratenko, W Mlynarski, G Notheis, M Führer, I Schmid and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Treosulfan-based conditioning for inborn errors of immunity.Therapeutic advances in hematology · 2021
    Review
  6. Article
  7. Article
  8. Review
  9. Hereditary myeloid malignancies.Best practice & research. Clinical haematology · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Hematopoietic stem cell transplantation for primary immunodeficiencies.Hematology/oncology clinics of North America · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

M H AlbertDepartment of Pediatric Hematology/Oncology, Dr von Haunersches Kinderspital der LMU, Munich, Germany. michael.albert@med.lmu.de
A R Gennery
J Greil
C M Cale
K Kalwak
I Kondratenko
W Mlynarski
G Notheis
M Führer
I Schmid
B H Belohradsky
Ludwig-Maximilians-Universität München · DEMünchen Klinik · DEMedical University of Lodz · PLNewcastle University · GBRussian Children's Clinical Hospital · RUUniversity College London · GBUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nijmegen breakage syndrome (NBS) is characterized by chromosomal instability, radiation hypersensitivity, characteristic facial appearance, immunodeficiency and strong predisposition to lymphoid malignancy. Traditionally, NBS patients have not undergone hematopoietic SCT (HSCT) owing to concerns about increased toxicity. We therefore report on the HSCT experience in NBS patients in Europe. Six patients were transplanted either for resistant or secondary malignancy (four patients) or severe immunodeficiency (two patients). Five patients received reduced-intensity conditioning regimens. After a median follow-up of 2.2 years, five patients are alive and well. One patient who received myeloablative conditioning died from sepsis before engraftment. Acute GVHD grades I-II occurred in three of five patients, mild chronic GVHD in one. All five surviving patients exhibit restored T-cell immunity. The experience in these six patients suggests that HSCT in NBS is feasible, can correct the immunodeficiency and effectively treat malignancy. Acute toxicity seems to be reasonable with reduced-intensity conditioning regimens.

Indexed as

Hematopoietic Stem Cell TransplantationAdolescentChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantMaleNijmegen Breakage SyndromeRetrospective StudiesTransplantation ChimeraTransplantation Conditioning

Identifiers

PMID19684627
OpenAlexW2157741249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.